Android app on Google Play

Medtronic, Inc. (MDT) Reports In-Line Q3 EPS of 84c; Reaffirms FY12 Sales Outlook

February 21, 2012 7:16 AM EST Send to a Friend
Medtronic, Inc. (NYSE: MDT) reported Q3 EPS of $0.84, in-line with the analyst estimate of $0.84. Revenue for the quarter came in at $3.92 billion versus the consensus estimate of $3.99 billion.

Reaffirms its FY12 sales guidance, sees EPS of $3.44-$3.47.

For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment